Number | Ticker | Exchange | Market Cap | Price | 52 Weeks Low | 52 Weeks High | Analyst Decision |
---|---|---|---|---|---|---|---|
1 | Nasdaq | $73.2B | $0.00 | $37.31 | $87.78 | Strong Buy | |
2 | Nasdaq | $50.4B | $0.00 | $99.00 | $178.43 | Buy | |
3 | Nasdaq | $47.1B | $0.00 | $201.54 | $310.50 | Buy | |
4 | Nasdaq | $46.7B | $0.00 | $33.60 | $50.93 | Strong Buy | |
5 | Nasdaq | $46.5B | $0.00 | $108.45 | $167.56 | Buy | |
6 | Nasdaq | $46.5B | $0.00 | $146.00 | $243.40 | Buy | |
7 | Nasdaq | $46.1B | $0.00 | $62.58 | $82.54 | Buy | |
8 | Nasdaq | $45.5B | $0.00 | $64.89 | $83.00 | Buy | |
9 | Nasdaq | $45.5B | $0.00 | $35.94 | $48.11 | Buy | |
10 | Nasdaq | $45.5B | $0.00 | $148.25 | $413.34 | Buy | |
11 | Nasdaq | $45.1B | $0.00 | $169.36 | $201.66 | Strong Buy | |
12 | Nasdaq | $44.8B | $0.00 | $55.19 | $74.90 | Buy | |
13 | Nasdaq | $44.4B | $0.00 | $216.68 | $338.92 | Buy | |
14 | Nasdaq | $43.9B | $0.00 | $69.24 | $88.07 | Buy | |
15 | Nasdaq | $43.4B | $0.00 | $55.47 | $114.01 | Buy | |
16 | Nasdaq | $43.2B | $0.00 | $114.00 | $186.74 | Strong Buy | |
17 | Nasdaq | $43.0B | $0.00 | $115.21 | $203.75 | Buy | |
18 | Nasdaq | $42.6B | $0.00 | $74.67 | $95.22 | Buy | |
19 | Nasdaq | $42.3B | $0.00 | $486.74 | $642.45 | Buy | |
20 | Nasdaq | $42.2B | $0.00 | $8.06 | $11.33 | Buy | |
21 | Nasdaq | $42.1B | $0.00 | $145.02 | $198.33 | Buy | |
22 | Nasdaq | $41.5B | $0.00 | $122.13 | $163.30 | Buy | |
23 | Nasdaq | $41.0B | $0.00 | $438.86 | $1,016.96 | Strong Buy | |
24 | RMDResMed Inc. | Nasdaq | $40.7B | $0.00 | $199.92 | $293.81 | Buy |
25 | Nasdaq | $40.2B | $0.00 | $71.55 | $99.20 | Buy | |
26 | Nasdaq | $39.6B | $0.00 | $441.95 | $664.28 | Strong Buy | |
27 | Nasdaq | $37.5B | $0.00 | $239.78 | $322.92 | Buy | |
28 | Nasdaq | $37.2B | $0.00 | $1,300.00 | $2,402.52 | Buy | |
29 | Nasdaq | $37.0B | $0.00 | $104.93 | $135.17 | Buy | |
30 | Nasdaq | $37.0B | $0.00 | $34.74 | $69.98 | Strong Buy | |
31 | Nasdaq | $35.5B | $0.00 | $112.70 | $225.64 | Buy | |
32 | Nasdaq | $35.3B | $0.00 | $10.11 | $26.70 | Strong Buy | |
33 | Nasdaq | $34.2B | $0.00 | $100.48 | $151.16 | Buy | |
34 | Nasdaq | $34.0B | $0.00 | $35.00 | $97.79 | Strong Buy | |
35 | Nasdaq | $33.8B | $0.00 | $151.81 | $216.10 | Buy | |
36 | Nasdaq | $32.4B | $0.00 | $81.08 | $108.74 | Buy | |
37 | Nasdaq | $32.1B | $0.00 | $72.81 | $118.24 | Buy | |
38 | Nasdaq | $31.3B | $0.00 | $150.75 | $225.70 | Buy | |
39 | Nasdaq | $31.0B | $0.00 | $134.65 | $237.34 | Strong Buy | |
40 | Nasdaq | $30.9B | $0.00 | $89.99 | $125.68 | Buy | |
41 | Nasdaq | $30.3B | $0.00 | $121.03 | $175.58 | Buy | |
42 | Nasdaq | $29.8B | $0.00 | $121.43 | $186.20 | Buy | |
43 | Nasdaq | $29.5B | $0.00 | $11.97 | $26.44 | Buy | |
44 | Nasdaq | $29.4B | $0.00 | $9.00 | $27.43 | Strong Buy | |
45 | Nasdaq | $28.5B | $0.00 | $1.71 | $3.00 | Strong Buy | |
46 | Nasdaq | $28.2B | $0.00 | $17.25 | $33.47 | Buy | |
47 | Nasdaq | $27.8B | $0.00 | $115.59 | $143.79 | Buy | |
48 | Nasdaq | $27.8B | $0.00 | $320.89 | $697.91 | Strong Buy | |
49 | AEEAmeren Corporation | Nasdaq | $27.3B | $0.00 | $85.27 | $105.67 | Buy |
50 | Nasdaq | $27.2B | $0.00 | $31.22 | $38.23 | Buy |
The FinQuota filters have identified what they believe to be the "Best 52 Week Low Penny Stocks to Buy in October 16, 2025" to buy now. However, please note that this information should not be considered as financial advice, as investing involves risks. We strongly recommend consulting with a qualified financial advisor before making any decisions regarding buying or selling stocks.